CEP-28122

CAT: 0804-HY-18030Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-18030Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CEP-28122 is a highly potent and selective orally active ALK inhibitor with IC50 of 1.9 ± 0.5 nM in an enzyme-based TRF assay. IC50 value: 1.9 ± 0.5 nM Target: ALK in vitro: CEP-28122 is a potent inhibitor of recombinant ALK activity and cellular ALK tyrosine phosphorylation. CEP-28122 also inhibits Flt4 with IC50 of 46 ±10 nM. CEP-28122 induces concentration-dependent growth inhibition/cytotoxicity of ALK-positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroblastoma cells. [1] in vivo: CEP-28122 displays dose-dependent inhibition of ALK tyrosine phosphorylation in tumor xenografts in mice, with substantial target inhibition (>90%) for more than12 hours following single oral dosing at 30 mg/kg. Dose-dependent antitumor activity was observed in ALK-positive ALCL, NSCLC, and neuroblastoma tumor xenografts in mice administered CEP-28122 orally, with complete/near complete tumor regressions observed following treatment at doses of 30 mg/kg twice daily or higher. [1]
CAS Number
[1022958-60-6]
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK)
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CEP-28122.html
Solubility
10 mM in DMSO
Smiles
O=C([C@H]1[C@](C2)([H])C=C[C@]2([H])[C@H]1NC3=NC(NC4=CC=C5C(CC[C@@H](N6CCOCC6)CC5)=C4OC)=NC=C3Cl)N
Molecular Formula
C28H35ClN6O3
Molecular Weight
539.07
References & Citations
[1]Cheng M, et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 2012 Mar;11 (3) :670-679.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-100946-01CEP-40783
HY-123172CEP-2563
HY-117909-01CEP-40125
HY-16135-01CEP-11981
HY-15343-01CEP-33779
HY-10412CEP-1347
HY-14243CEP-14083
HY-13590CEP-7055
HY-P991435CEP-37248
HY-15334CEP-5214

Alternative Products

CatalogName
M10107-01CEP-28122
A13744-1CEP-28122 1mg
MBS3606985-01CEP-28122 mesylate
A13744-25CEP-28122 25mg
A13744-2CEP-28122 2mg
A13744-5CEP-28122 5mg
A13744-10CEP-28122 10mg
MBS5752902CEP-28122 mesylate salt
T86040-01CEP-28122 mesylate hydrochloride
BUP07057-01CEP-28122 mesylate salt (1022958-60-6 free base)

Popular Products